TARIN TRAVIESO: Open Payments
NPI 1477285948 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,172 in 51 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $20 · 2025 $2,172
Food & beverage: $2,000Education: $172
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 7 | $494 |
| Janssen Biotech, Inc. | 9 | $492 |
| Arcutis Biotherapeutics, Inc. | 4 | $294 |
| MERZ NORTH AMERICA, INC. | 1 | $150 |
| Janssen Scientific Affairs, LLC | 2 | $143 |
| Novartis Pharmaceuticals Corporation | 5 | $114 |
| ABBVIE INC. | 6 | $105 |
| UCB, Inc. | 3 | $98 |
| Incyte Corporation | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 3 | $57 |
Products named: TREMFYA, NEMLUVIO, Zoryve, Xeomin, SKYRIZI, Bimzelx, DUPIXENT, OPZELURA.
Industry payments across TX — which companies pay providers there.
